Select your Market

Global
Africa
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
Congo
Congo Democratic Republic
Djibouti
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Ivory Coast
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Reunion Islands
Rwanda
Saint Helena
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe
Asia
Bahrain
Bangladesh
China, mainland
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kuwait
Lebanon
Malaysia
Oman
Palestine
Philippines
Qatar
Saudi Arabia
Singapore
South Korea
Syria
Taiwan
Thailand
Turkey
United Arab Emirates
Vietnam
Yemen
Europe
Albania
Austria
Baltic Region
Belarus
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Netherlands
North Macedonia
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Türkiye
Ukraine
United Kingdom
Latin America
Argentina
Aruba
Bahamas
Barbados
Belize
Bolivia
Brazil
Central America
Chile
Colombia
Costa Rica
Cuba
Curacao-NL Antillen
Ecuador
El Salvador
Guatemala
Haiti
Honduras
Jamaica
Mexico
Nicaragua
Panama
Paraguay
Perú
República Dominicana
Trinidad and Tobago
Uruguay
Venezuela
North America
Canada
United States of America
Oceania
Australia
New Zealand
Global
CAREERS

Profitable Growth Despite Challenges

In fiscal 2022, the Group delivered solid growth in net sales and EBITDA pre.

Key facts and Forecast

Results of fiscal 2022

  • Group net sales rise 12.9% to € 22.2 billion
  • EBITDA pre up 12.2% to € 6.8 billion
  • “Big 3” businesses generate almost 90% of organic sales growth
  • Dividend proposal: € 2.20 per share 

Forecast for fiscal 2023

  • Net sales: slight to solid organic growth
  • EBITDA pre: organically moderate decline to about stable
  • Negative foreign exchange effects expected

Overview: Business performance in fiscal 2022

 

Fiscal 2022              
(in € billion)

Change (in %, compared to fiscal 2021)

Organic growth (in %, compared to fiscal 2021)

Group net sales

22.2

12.9

6.4

EBITDA pre

6.8

12.2

6.1

Life Science sales

10.4

15.4

8.2

Healthcare sales

7.8

10.6

5.5

Electronics sales

4.0

11.3

3.7

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

We delivered profitable growth in fiscal 2022 despite challenges.

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

ADDITIONAL INFORMATION

Financial Report
 

Downloads for the Media

Additional Downloads

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Conference calls for the media and analysts

  • The annual press conference and the conference call for analysts are available as a recording

Related News

View All News

  1. Press Releases

    Fiscal 2022: Merck KGaA, Darmstadt, Germany, Delivers Profitable Growth Despite ...

    Merck KGaA, Darmstadt, Germany delivered profitable growth despite challenges in fiscal 2022. Group net sales increased by 12.9% (organically: 6.4%) to € 22,232 million compared with the previous year.

    2023/03/02

Esther Döringer

Media Relations

+49 151 1454-7809

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271